The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review
Open accessAbstract
Moderate alcohol consumption in patients with nonalcoholic fatty liver disease (NAFLD) is common, yet the effects on cardiovascular and liver health are unclear. Moderate alcohol use is associated with improved insulin sensitivity and decreased cardiovascular mortality in the general population, but whether similar benefits would be observed in persons with NAFLD remains largely unstudied. There is significant overlap in the pathogenesis of alcoholic liver disease (ALD) and NAFLD, although studies of ALD have focused on pathological alcohol intake and few mechanistic studies of moderate alcohol use in NAFLD exist. We undertook a critical review of the effect of moderate alcohol use on cardiovascular and liver disease in patients with NAFLD. A total of seven observational studies met the criteria for inclusion (one for cardiovascular endpoints and six for liver endpoints). Insufficient studies have assessed the association of moderate alcohol use with cardiovascular outcomes. There was a positive association between moderate alcohol use and decreased NASH and fibrosis; however, heavy episodic drinking may accelerate fibrosis progression and moderate alcohol use may increase the risk of hepatocellular carcinoma in patients with advanced fibrosis. Significant methodological limitations were present, including incomplete adjustment for confounding factors and failure to measure lifetime use or the pattern of alcohol intake. Thus, a strong recommendation of benefit of moderate alcohol use in NAFLD cannot be made. There remains a need for additional high-quality longitudinal studies that evaluate both cardiovascular and liver outcomes among NAFLD patients with moderate or lesser degrees of alcohol use. (Hepatology 2017;65:2090-2099).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Table 8. Factors associated with a higher risk of HCC occurrence in MASLD.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [533]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597 · cited 1×
“Measurement of alcohol use with standardized and validated questionnaires (42, 43) brings a higher level of rigor to the measurement and facilitates comparisons across studies.”
BackgroundPrevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Williams, C. D., Stengel, J. Z., Asike, M., Torres, D. M., Shaw, J. C., Contreras, M., Landt, C. L., & Harrison, S. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,182
Self-citationZhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · cited 1×
“In fact, patients with nonalcoholic steatohepatitis (NASH) have increased microbiome-mediated endogenous alcohol production compared to obese and healthy controls.((29)) Moderate alcohol use is associated with small intestinal bacterial overgrowth compared to teetotalers.”
BackgroundDixon, J. B., Bhathal, P. S., & O’Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,369
Alcohol consumption and mortality among middle-aged and elderly U.S. adults
Thun, M. J., Peto, R., Lopez, A. D., Monaco, J. H., Henley, S. J., Heath, C. W., & Doll, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372401 · Cited by 1,313
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
Cited by
Sorted by citations
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Crabb, D. W., Im, G. Y., Szabó, G., Mellinger, J. L., & Lucey, M. R. (2019) · Hepatology · doi:10.1002/hep.30866 · Cited by 938
(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 545
Araújo, A. R., Rosso, N., Bedogni, G., Tiribelli, C., & Bellentani, S. (2018) · Liver international (Print) · doi:10.1111/liv.13643 · Cited by 370
Fibrosis and alcohol-related liver disease
Lackner, C., & TINIAKOS, D. G. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.003 · Cited by 326
Predictors of early and late hepatocellular carcinoma recurrence
Nevola, R., Ruocco, R., Criscuolo, L., Villani, A., Alfano, M., Beccia, D., Imbriani, S., Claar, E., Cozzolino, D., Sasso, F. C., et al. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i8.1243 · Cited by 300
Kalligeros, M., Vassilopoulos, A., Vassilopoulos, S., Victor, D. W., Mylonakis, E. E., & Noureddin, M. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.11.003 · Cited by 243
Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
Nguyen, V. H., Le, M. H., Cheung, R. C., & Nguyen, M. H. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.05.029 · Cited by 217
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207
Aguado, D. M., Calleja, J. L., Vilar‐Gómez, E., Iruzubieta, P., Rodríguez-Duque, J. C., Barrio, M. D., Puchades, L. G., Rivera‐Esteban, J., Perelló, C., Puente, Á., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.036 · Cited by 206
Alcohol Use in Patients with Chronic Liver Disease
Fuster, D., & Samet, J. H. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1715733 · Cited by 207
Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)
Fan, J., Wei, L., & Zhuang, H. (2018) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12685 · Cited by 198
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Zhou, X., Targher, G., Byrne, C. D., Somers, V. K., Kim, S. U., Chahal, C. A. A., Wong, V. W., Cai, J., Shapiro, M. D., Eslam, M., et al. (2023) · Hepatology International · doi:10.1007/s12072-023-10543-8 · Cited by 203
Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
Tana, C., Ballestri, S., Ricci, F., Vincenzo, A. D., Ticinesi, A., Gallina, S., Giamberardino, M. A., Cipollone, F., Sutton, R., Vettor, R., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173104 · Cited by 189
Staufer, K., Huber-Schönauer, U., Strebinger, G., Pimingstorfer, P., Suesse, S., Scherzer, T. M., Paulweber, B., Ferenci, P., Stimpfl, T., Yegles, M., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.04.040 · Cited by 190
Risks of light and moderate alcohol use in fatty liver disease: follow-up of population cohorts
Åberg, F., Puukka, P., Salomaa, V., Männistö, S., Lundqvist, A., Valsta, L., Perola, M., Färkkilä, M., & Jula, A. (2020) · Hepatology · doi:10.1002/hep.30864 · Cited by 176
Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations
Parker, R., Kim, S.-J., & Gao, B. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.116 · Cited by 175
Boyle, M., Masson, S., & Anstee, Q. M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.006 · Cited by 162
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
Idalsoaga, F., Kulkarni, A. V., Mousa, O. Y., Arrese, M., & Arab, J. P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00448 · Cited by 136
Hajifathalian, K., Torabi Sagvand, B., & McCullough, A. J. (2019) · Hepatology · doi:10.1002/hep.30226 · Cited by 128
Mitchell, T., Jeffrey, G. P., de Boer, B., MacQuillan, G. C., Garas, G., Ching, H. L., Hamdorf, J. M., & Adams, L. A. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0133-5 · Cited by 90
Kimura, T., Tanaka, N., Fujimori, N., Sugiura, A., Yamazaki, T., Joshita, S., Komatsu, M., Umemura, T., Matsumoto, A., & Tanaka, E. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i13.1440 · Cited by 88
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions
Åberg, F. O., & Färkkilä, M. A. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1701443 · Cited by 87
γδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming
Torres‐Hernandez, A., Wang, W., Nikiforov, Y., Tejada, K., Torres, L., Kalabin, A., Adam, S., Wu, J., Lu, L., Chen, R., et al. (2020) · Hepatology · doi:10.1002/hep.30952 · Cited by 80
Fatty Liver Disease: Diagnosis and Stratification
Saiman, Y., Duarte‐Rojo, A., & Rinella, M. E. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042220-020407 · Cited by 78
Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease
VanWagner, L. B., Ning, H., Allen, N. B., Ajmera, V., Lewis, C. E., Carr, J. J., Lloyd-Jones, D. M., Terrault, N. A., & Siddique, J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.012 · Cited by 74
Self-citationChang, Y., Ryu, S., Kim, Y., Cho, Y. K., Sung, E., Kim, H., Ahn, J., Jung, H. S., Yun, K. E., Kim, S., et al. (2019) · Hepatology · doi:10.1002/hep.30867 · Cited by 74
Jarvis, H., O'Keefe, H., Craig, D., Stow, D., Hanratty, B., & Anstee, Q. M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-049767 · Cited by 71
Tamaki, N., Kimura, T., Wakabayashi, S., Umemura, T., Kurosaki, M., Loomba, R. S., & Izumi, N. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18015 · Cited by 69
The role of adipose tissue in fatty liver diseases
Parker, R. (2018) · Liver Research · doi:10.1016/j.livres.2018.02.002 · Cited by 75
Åberg, F., Färkkilä, M., & Männistö, V. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14271 · Cited by 63
Yang, A. H., Tincopa, M. A., Tavaglione, F., Ajmera, V. H., Richards, L., Amangurbanova, M., Butcher, C. H., Hernandez, C., Madamba, E. V., Singh, S., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-332917 · Cited by 63
Self-citationAlcohol Consumption in Concomitant Liver Disease: How Much is Too Much?
Hagström, H. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0343-0 · Cited by 62
Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice
Shen, H., Jiang, L., Lin, J. D., Omary, M. B., & Rui, L. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124376 · Cited by 62
Zeng, J., Qin, L., Jin, Q., Yang, R., Ning, G., Su, Q., YANG, Z. K., & Fan, J. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.01.006 · Cited by 55
Liu, Z., Song, C., Suo, C., Fan, H. X., Zhang, T., Li, J., & Chen, X. (2022) · BMC Medicine · doi:10.1186/s12916-022-02622-8 · Cited by 55
Alkhouri, N., Almomani, A., Le, P., Payne, J. Y., Asaad, I., Sakkal, C., Vos, M. B., Noureddin, M., & Kumar, P. N. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02430-7 · Cited by 48
Bullón‐Vela, V., Abete, I., Tur, J. A., Pintó, X., Corbella, E., Martínez‐González, M. Á., Toledo, E., Corella, D., Macías, M., Tinahones, F. J., et al. (2019) · Nutrition · doi:10.1016/j.nut.2019.110620 · Cited by 46
Pais, R., & Maurel, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061161 · Cited by 47
Role of Alcohol Oxidative Metabolism in Its Cardiovascular and Autonomic Effects
El‐Mas, M. M., & Abdel‐Rahman, A. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-6260-6_1 · Cited by 43
Hwang, S., Ren, T., & Gao, B. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0100 · Cited by 43
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Brar, G., & Tsukamoto, H. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-018-01542-w · Cited by 44
Pose, E., Pera, G., Torán‐Monserrat, P., Gratacós‐Ginès, J., Avitabile, E., Expósito, C., Díaz, A., Graupera, I., Rubio, A. B., Ginès, P., et al. (2021) · Liver International · doi:10.1111/liv.14830 · Cited by 41
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?
Petroni, M. L., Brodosi, L., Marchignoli, F., Musio, A., & Marchesini, G. (2019) · Nutrients · doi:10.3390/nu11123048 · Cited by 42
Experimental models of metabolic and alcoholic fatty liver disease
Buyco, D. G., Martin, J., Jeon, S., Hooks, R., Lin, C., & Carr, R. M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i1.1 · Cited by 41
Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis
Ciaula, A. D., Bonfrate, L., Krawczyk, M. J., Frühbeck, G., & Portincasa, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052636 · Cited by 37
Nomura, T., Ono, M., Kobayashi, K., Akaiwa, Y., Ayaki, M., Ogi, T., Ogi, M., Takahashi, H., Ishikawa, K., Morishita, A., et al. (2023) · Hepatology Research · doi:10.1111/hepr.13935 · Cited by 38
Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis
Ratziu, V., Ghabril, M., Romero‐Gómez, M., & Svegliati‐Baroni, G. (2018) · Transplantation · doi:10.1097/tp.0000000000002483 · Cited by 40
Zhou, X., Li, Y., Zhang, X., Guan, Y., Puentes, Y., Zhang, F., Speliotes, E. K., & Ji, L. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3156 · Cited by 38
Alcohol, smoking and the liver disease patient
Hagström, H. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.003 · Cited by 36
Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients
Cheung, A. C., Figueredo, C. J., & Rinella, M. E. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000058 · Cited by 35
Non-alcoholic fatty liver diseases: current challenges and future directions
Roeb, E. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-3760 · Cited by 34
The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study
Tyrovolas, S., Panagiotakos, D. B., Georgousopoulou, E. N., Chrysohoou, C. A., Skoumas, J., Pan, W., Tousoulis, D. M., & Pitsavos, C. E. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819858039 · Cited by 34
Wong, R. J., Yang, Z., Cheung, R. C., Singal, A. K., Do, A., Ahmed, A., & Yeoh, A. J. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.02.032 · Cited by 32
Cholankeril, G. T., Gadiparthi, C., Yoo, E. R., Dennis, B. B., Li, A. A., Hu, M., Wong, K., Kim, D., & Ahmed, A. (2018) · Transplantation · doi:10.1097/tp.0000000000002471 · Cited by 32
Rice, B. A., Naimi, T. S., & Long, M. T. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.10.039 · Cited by 32
Eroglu, E. I., Huang, B., Ahmadi, M. N., Johnson, N. A., El-Omar, E. M., & Stamatakis, E. A. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00923-4 · Cited by 28
Effect of alcohol consumption on nonalcoholic fatty liver disease
Weng, G., & Dunn, W. (2019) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.09.02 · Cited by 29
Hu, Y., Zhong, R., Li, H., & Zou, Y. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2020.1750031 · Cited by 28
Acierno, C., Barletta, F., Caturano, A., Nevola, R., Sasso, F. C., Adinolfi, L. E., & Rinaldi, L. (2025) · Nutrients · doi:10.3390/nu17132229 · Cited by 33
Ethnopharmacological Applications Targeting Alcohol Abuse: Overview and Outlook
Singh, L., Joshi, T., Tewari, D., Echeverría, J., Mocan, A., Sah, A. N., Parvanov, E. D., Tzvetkov, N. T., Feei, Z., Lee, Y. Y., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01593 · Cited by 26
Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease
Kwon, I., Jun, D. W., & Moon, J. (2018) · Gut and Liver · doi:10.5009/gnl18175 · Cited by 24
Stankevič, E., Israelsen, M. E., Juel, H. B., Madsen, A. L., Ängquist, L. H., Aldiss, P., Torp, N., Johansen, S., Hansen, C. D., Hansen, J. K., et al. (2023) · Liver International · doi:10.1111/liv.15692 · Cited by 22
Identifying High-Risk NASH Patients: What We Know so Far
Schulz, M., & Tacke, F. (2020) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s265473 · Cited by 21
Mixed steatohepatitis: more questions than answers (Part 1)
Raikhelson, K. L., Александровна, К. Э., & Владимировна, П. Е. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.12.200470 · Cited by 20
Trembling, P. M., Apostolidou, S., Gentry‐Maharaj, A., Parkes, J., Ryan, A., Tanwar, S., Burnell, M., Jacobs, I. J., Menon, U., & Rosenberg, W. M. (2017) · BMC Public Health · doi:10.1186/s12889-017-4518-y · Cited by 18
Martínez‐Urbistondo, D., Pérez-Díaz-del-Campo, N., Landecho, M. F., & Martínez, J. A. (2024) · Current Obesity Reports · doi:10.1007/s13679-024-00560-5 · Cited by 20
Eekelen, E. W.-V., Beulens, J. W. J., Geelen, A., Schrauwen‐Hinderling, V. B., Lamb, H. J., Roos, A., Rosendaal, F. R., & de Mutsert, R. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy313 · Cited by 17
García‐Calvo, X., Bolao, F., Sanvisens, A., Zuluaga, P., Tor, J., Muga, R., & Fuster, D. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14228 · Cited by 17
Zhou, Y., Hua, J., & Huang, Z. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1022977 · Cited by 15
Akahane, T., Namisaki, T., Kaji, K., Moriya, K., Kawaratani, H., Takaya, H., Sawada, Y., Shimozato, N., Fujinaga, Y., Furukawa, M., et al. (2020) · Nutrients · doi:10.3390/nu12041036 · Cited by 15
Bucher, S., Begriche, K., Catheline, D., Trak-Smayra, V. E., Tiaho, F., Coulouarn, C., Pinon, G., Lagadic‐Gossmann, D., Rioux, V., & Fromenty, B. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02017-1 · Cited by 15
Wijarnpreecha, K. (2021) · Annals of Gastroenterology · doi:10.20524/aog.2021.0612 · Cited by 13
Ferri, S., Stefanini, B., Mulazzani, L., Alvisi, M., Tovoli, F., Leoni, S., Muratori, L., Lotti, T., Granito, A., Bolondi, L., et al. (2022) · Nutrients · doi:10.3390/nu14122493 · Cited by 14
Yoon, E. L., Park, H., Hong, H., Lee, C., Kim, M., Kang, B., & Jun, D. W. (2024) · Hepatology Research · doi:10.1111/hepr.14133 · Cited by 13
Non-alcoholic fatty liver disease
Verhaegh, P. L. M. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210428pv · Cited by 13
Lipoprotein Lipidomics as a Frontier in Non-Alcoholic Fatty Liver Disease Biomarker Discovery
Herrera-Marcos, L. V., Arbonés-Mainar, J. M., & Osada, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158285 · Cited by 12
Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes
Campani, C., Bensi, C., Milani, S., Galli, A., & Tarocchi, M. (2020) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s252506 · Cited by 12
Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Facts and Hopes
Adinolfi, L. E., Marrone, A., Izzi, A., & Craxì, A. (2025) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2025.103411 · Cited by 11
Romero‐Gómez, M., Arab, J. P., de Oliveira, C. P. M. S., Hernández, M., Arrese, M. A., Cortez‐Pinto, H., & Bataller, R. A. (2024) · Seminars in Liver Disease · doi:10.1055/s-0044-1785228 · Cited by 10
Sogabe, M., Okahisa, T., Kagawa, M., Ueda, H., Kagemoto, K., Tanaka, H., Kida, Y., Tomonari, T., Taniguchi, T., Okamoto, K., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.03.020 · Cited by 10
Yuan, C., Zhang, C., Geng, X., Feng, C., Su, Y., Wu, Y., Wang, Y., Chen, L., Ding, Q., Voortman, T., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-20663-x · Cited by 9
Zhu, Y., Xu, X., Fan, Z., Ma, X., Rui, F., Ni, W., Hu, X., Gu, Q., Shi, J., Wu, C., et al. (2024) · Liver International · doi:10.1111/liv.15849 · Cited by 10
Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no?
Protopapas, A. A. (2021) · Annals of Gastroenterology · doi:10.20524/aog.2021.0641 · Cited by 9
Sogabe, M., Okahisa, T., Kurihara, T., Kagawa, M., Ueda, H., Kawaguchi, T., Fukuya, A., Kagemoto, K., Tanaka, H., Kida, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-20124-8 · Cited by 9
Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease
Iruzubieta, P., González, M., Cabezas, J., Arias-Loste, M. T., & Crespo, J. (2018) · InTech eBooks · doi:10.5772/intechopen.72668 · Cited by 8
Histopathology of Nonalcoholic Fatty Liver Disease
TINIAKOS, D. G., & Sakellariou, S. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_3 · Cited by 8
TINIAKOS, D. G., Anstee, Q. M., Brunt, E. M., & Burt, A. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00005-3 · Cited by 7
Response to semaglutide of non-drinker subjects with type 2 diabetes
Petralli, G., Raggi, F., Zoppo, A. D., Rovera, C., Salvati, A., Brunetto, M. R., & Solini, A. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01344-6 · Cited by 6
Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors
Capinha, F., Carvalhana, S. C., & Cortez‐Pinto, H. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-08912-4 · Cited by 6
Fan, L., Zhu, X., Shingina, A., Kabagambe, E. K., Shrubsole, M. J., & Dai, Q. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001768 · Cited by 6
Lin, S., Chen, Y., & Fan, J. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12944 · Cited by 6
Non-alcoholic Fatty Liver Disease: A Global Public Health Issue
Kaya, E., & Yilmaz, Y. N. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_24 · Cited by 6
Alcohol: the role in nutrition and health
Suter, P. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818460-8.00025-3 · Cited by 5
Saitta, C., Caruso, A., Maimone, S., Filomia, R., Cacciola, I., Caccamo, G., Franzè, M. S., Pitrone, C., Alibrandi, A., Gaeta, M., et al. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-02971-5 · Cited by 5
Adusumalli, S., Jamwal, R., Leggio, L., & Akhlaghi, F. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.121820 · Cited by 5
Sex-Specific Cardiometabolic Profiles and Severity of Liver Fibrosis
Albhaisi, S. A. M., Kim, S. S., Terrault, N. A., & Dodge, J. L. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.0863 · Cited by 6
Self-citationArmstrong, M. J., Mellinger, J. L., & Trivedi, P. J. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0237-y · Cited by 4
Metadata
- Authors
- Ajmera, V. H., Terrault, N. A., & Harrison, S. A.
- Affiliations
- University of California, San Francisco (US)
- Brooke Army Medical Center (US)
- Corresponding author
- Ajmera, Veeral H.
- Venue
- Hepatology
- Published
- 2017-04-28
- Volume
- 65
- Issue
- 6
- Pages
- 2090-2099
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- PMC
- PMC5444963
- OpenAlex
- W2573357558
- Cited by
- 137
- References
- 49
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 18 · 2023: 9 · 2022: 16 · 2021: 13 · 2020: 19 · 2019: 22 · 2018: 17 · 2017: 7
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Department of Defense
- National Institute of Diabetes and Digestive and Kidney Diseases (T32 5T32DK060414, T32DK060414)
- U.S. Army Medical Department
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- moderate drinking, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, liver fibrosis, hepatocellular carcinoma, cardiovascular mortality, insulin sensitivity, binge drinking, alcoholic liver disease, alcohol and liver disease
- MeSH terms
- Alcohol Drinking, Biopsy, Needle, Cardiovascular Diseases, Female, Carcinoma, Hepatocellular, Humans, Immunohistochemistry, Liver Diseases, Alcoholic, Liver Neoplasms, Longitudinal Studies, Male, Middle Aged, Prognosis, Severity of Illness Index, Disease Progression, Risk Assessment, Needs Assessment, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
